{"nct_id":"NCT00613106","title":"Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2007-09","start_date_type":null,"primary_completion_date":"2008-10","primary_completion_date_type":"ACTUAL","completion_date":"2008-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}